Holliston, Mass.-based Biostage Inc. named James Shmerling as a board member.

Shmerling is the president and CEO of Connecticut Children's Medical Center.

"Biostage is collaborating with Connecticut Children's Medical Center to translate our Cellframe technology from pre-clinical studies to clinical trials to address pediatric esophageal atresia, and the addition of Jim to our board supports the vision of this collaboration," Biostage CEO James McGorry said in a statement.

Biostage is a biotechnology company that engages in developing bioengineered organ implants.